The association between nuclear NRDP1 levels and PSA recurrence in prostate cancer patients indicates that nuclear NRDP1 has clinical relevance and that further investigation of how NRDP1 translocation occurs and how nuclear NRDP1 levels are regulated as well as the identification of specific nuclear targets of nuclear NRDP1 is warranted. Here, RNF41 is linked to prostate carcinoma.